Public Health, Policy and Ethics

(P-PH-1) Early experience of recruiting donors into a large cohort study and biobank

(P-PH-2) Investigating the relevance of anti-spike nonreactive, anti-nucleocapsid reactive profiles identified in a large SARS-CoV-2 blood donor serosurveillance study

(P-PH-3) Next Steps for Implementing Intraoperative Autotransfusion to Address the Global Transfusion Gap: Conclusions from an International Working Group

(P-PH-4) Putting Blood Donors at the Heart of Infectious Disease Surveillance

(P-PH-5) Qualification of High Titer COVID-19 Convalescent Plasma with an Anti-SARS-CoV-2 IgG Quantitative Test

(P-PH-6) Regulating Blood Systems in the WHO Eastern Mediterranean Region

(P-PH-7) Risk factors for recent HIV infection in US blood donors in the period 2015 - 2022

(P-PH-8) The Evolution and Interpretation of Seroprevalence of SARS-CoV-2 antibodies among Blood Donors from the Beta to Omicron Variant Driven Waves

(P-PH-9) Universal Health Coverage and Essential Medicines: Impact on Blood Availability and Safety in Resource Restricted Countries